In the early phases of malignancy, TGF‐β acts as a tumor suppressor, counteracting tumor growth, moderating cell proliferation, triggering apoptosis, and preserving harmony within the tumor microenvironment [90]. The gene discussed is TGFB1; the disease is neoplasm.